Daniel Elías Martín Herranz

Critic
DISC Type : C

Director, Multi-Omics & AI at AstraZeneca

London, England, United Kingdom

Overview

Daniel is the Director of Multi-Omics & AI at AstraZeneca, leveraging large-scale data and machine learning for drug discovery. He is also the co-founder of Hurdle, a diagnostics company. He earned his PhD from the University of Cambridge, where his research focused on the epigenetic ageing clock in humans.

Outside of his primary roles, Daniel is an active contributor to the scientific community, publishing numerous papers and making his research publicly available on platforms like GitHub. His interests include golf, diving, badminton, tennis, and skiing, showcasing a passion for both analytical and athletic pursuits.

During his PhD, Daniel launched his first startup, focusing on translating his epigenetics and wellbeing research into real-world applications.

Personality Overview

Information Seeker

ROI Driven

Objective Thinker

They prefer to do logical analysis and value evidence over emotions.  They don’t appreciate bells and whistles unless backed by data. They enjoy working alone and do not rely on others very often.

Topics They Care About

AI in Drug Discovery
His current role at AstraZeneca and recent publications focus on using AI and multi-modal data to discover new drugs and advance precision medicine.
Epigenetic Aging
This was the focus of his PhD thesis at the University of Cambridge and a recurring theme in his research and publications.
Biomarker Innovation
As co-founder and CSO of Hurdle, he led the development of novel biomarkers and diagnostics, a core theme throughout his career.

Media Appearances

Daniel has no verified media appearances

Work History

10-2025
Director, Multi-Omics & AI at AstraZeneca
10-2025
Co-Founder at Hurdle
12-2017 - 9-2025
CSO and co-founder at Hurdle
10-2015 - 4-2019
PhD Student at EMBL-EBI
5-2015 - 8-2015
Research Intern at University of Cambridge

Education

2015 - 2019
Doctor of Philosophy - PhD from University of Cambridge
2014 - 2015
Master's Degree from University of Cambridge

More Information

Social Presence :

Prographics :

Exp : 11 Location : London, England, United Kingdom Job Level : Mid-senior Designation : Director, Multi-Omics & AI at AstraZeneca
URL has been copied!

Insights For Selling To Daniel Elías

During A Call Or A Meeting

DO's

  • Leverage facts and figures wherever possible; use percentages, numbers etc.
  • Keep some extra margin while sharing pricing, they are likely to negotiate later
  • Tell them what ROI they can expect

DONT's

  • Make extra effort to not seem pushy or confrontational
  • Avoid phrases like ‘trust me’, ‘others just love’ etc.
  • Do not use very emotional or colorful language

When Cold Calling

When Writing An Email

While Negotiating & Closing

    The secret to closing fast with Daniel Elías is

  • Strong evidence of ROI, effective pricing, and proven data points matter the most to them.
  • Will you ever get a clear answer from Daniel Elías

  • It is not very hard for them to say no if they are not convinced about the decision.

Insights For Deal Planning

    How fast (or slow) will Daniel Elías move?

  • They are neither the fastest nor the slowest decision makers, they are somewhere in the middle.
  • Can Daniel Elías take some risk or not?

  • They can bear some risk if their analysis backs the decision.

You And Daniel Elías

Personality Compatibility


Other AstraZeneca Employees

Explore more public profiles from related professionals at the same organization.

More Profiles

Discover additional public profiles from our index.

Search more profiles

Looking for someone else? Search here for anyone.

Or visit Humantic AI to know more.